Venlafaxine induced serotonin syndrome occurring after abstinence from phenelzine for more than two weeks.
Kolecki
P
P
D000328:Adult; D003511:Cyclohexanols / Q000009:adverse effects*; D004334:Drug Administration Schedule; D006801:Humans; D008297:Male; D010624:Phenelzine / Q000009:adverse effects*; D012701:Serotonin / Q000378:metabolism*; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects*; D013375:Substance Withdrawal Syndrome / Q000378:metabolism*; D013577:Syndrome; D000069470:Venlafaxine Hydrochloride
D003511:Cyclohexanols; D010624:Phenelzine; D012701:Serotonin; D017367:Selective Serotonin Reuptake Inhibitors; D000069470:Venlafaxine Hydrochloride